Bring the realities of this devastating diagnosis for children and families to the forefront this September.
Childhood Cancer Awareness Month (CCAM) is a time to recognize, advocate for, and honor children who have been affected by cancer and the families that care for them. This September, the National Brain Tumor Society will highlight the devastating realities of a brain tumor diagnosis for children and families by sharing important progress being made in the field, raising resources to support ongoing and future research efforts, and providing opportunities for our community to help create change to last a lifetime.
As brain tumors are the leading cause of cancer-related death and the most commonly diagnosed solid cancer in children and adolescents age 19 and younger, the brain tumor community has an enormous stake and voice in Childhood Cancer Awareness Month.
We’ll share important progress being made in research to find better treatments and improve survival and quality of life, and to improve health care and support for families facing a pediatric brain tumor diagnosis.
Learn more about pediatric brain tumors below, including how the National Brain Tumor Society seeks to change that reality and is working to find better treatments and a cure.
will receive a brain tumor diagnosis in 2022
is the five-year survival rate for primary pediatric brain tumors
of cancer-related death among children and adolescents ages 0-19 years
are estimated to be living with a primary brain tumor in the U.S.
National Brain Tumor Society is committed to accelerating new treatments for pediatric brain tumor patients that will improve children’s survival and quality of life. Learn about how NBTS and our volunteers, donors, and partners are making change for the pediatric brain tumor community that will last a lifetime.
Your support is critical to ensuring the urgent, unmet needs of the pediatric brain tumor community continue to be heard and addressed. When you make a one-time or sustaining gift to NBTS, you have an immediate impact on the important work underway to conquer and cure brain tumors — once and for all.